Salvatierra O, Vincenti F, Amend W, Potter D, Iwaki Y, Opelz G, Terasaki P, Duca R, Cochrum K, Hanes D, Stoney R J, Feduska N J
Ann Surg. 1980;192(4):543-52. doi: 10.1097/00000658-198010000-00012.
In order to select MLC incompatible one-haplotype related donor-recipient pairs that would achieve better graft survival and in an effort to alter the recipient immune response, 45 patients received three fresh blood transfuions from their prospective kidney donors. Recipient sensitization was evaluated by cross-match testing weekly sera obtained during and after the blood transfusions against donor T- and B-lymphocytes at 5 C (cold) and 37 C (warm). Thirteen (29%) of the 45 potential related recipients developed a positive warm T-cell cross-match or a persistent warm B-cell cross-match to their blood donor and related transplantation was not performed. Thirty-two (71%) patients had an appropriate negative cross-match to their blood donor. Thirty of these patients subsequently received kidneys from their blood donor. Ninety-seven per cent of the kidneys are functioning from one to 25 months with a single graft failure due to a patient discontinuing immunosuppressive medication. In addition to the excellent graft survival there was an unusually low incidence of rejection episodes in the recipients of kidneys from their blood donor so that the posttransplant course paralleled that of HLA-identical siblings. This approach may have future application with two-haplotype mismatched donor-recipient pairs, both related and unrelated.
为了选择可能实现更好移植物存活的与次要组织相容性复合体(MLC)不匹配的单倍型相关供受者对,并努力改变受者的免疫反应,45名患者接受了来自其预期肾脏供者的三次新鲜输血。通过对输血期间及输血后每周采集的血清与供者T淋巴细胞和B淋巴细胞在5℃(冷)及37℃(温)条件下进行交叉配型试验来评估受者致敏情况。45名潜在的相关受者中,有13名(29%)对其献血者出现了阳性的温性T细胞交叉配型或持续性的温性B细胞交叉配型,因此未进行相关移植。32名(71%)患者与他们的献血者交叉配型结果合适为阴性。其中30名患者随后接受了来自其献血者的肾脏。97%的肾脏在1至25个月内功能良好,仅有1例移植失败,原因是患者停用了免疫抑制药物。除了移植物存活率高之外,接受来自其献血者肾脏的受者排斥反应发生率异常低,因此移植后的病程与HLA相同的同胞相似。这种方法未来可能适用于两个单倍型不匹配的供受者对,包括亲属和非亲属。